2010.06.09
美格公司创建Megs is founded
美格投资咨询Megs Investment Consulting
我们是帮助科创企业在全球生物科技领域寻找成功的投资机会和合作伙伴We help technology companies find investment opportunities and partners across the global biotechnology sector.
我们的服务理念是精准帮助科创公司寻找机会和合作伙伴，
协助在全球范围内促成交易。Our philosophy is to match technology companies precisely with opportunities and partners, and help transactions happen worldwide.
关于我们About Us
美格公司成立于2010年，前身为传媒公司，2016年进入科创投融资领域。目前在香港设有办事处，核心管理团队分布在美国和欧洲。我们主要为买卖交易双方提供服务，帮助寻找优质的项目投资人、稀缺的项目资源以及上下游的合作企业。Megs was founded in 2010. The firm began as a media company and moved into technology investment and financing in 2016. We maintain an office in Hong Kong, with our core management team based in the United States and Europe. We serve buyers and sellers, helping them find quality investors for their projects, scarce project resources, and partners up and down the value chain.
搭建桥梁、衔接沟通、安排会议、落地尽调，提前发现并化解不同国家之间因商业文化、法律差异而产生的问题，规避风险，促使双方合作并实现长期收益。We build the bridge — connecting the parties, arranging meetings and landing due diligence on the ground. We identify and resolve early the issues that arise between countries from differences in business culture and law, helping both sides avoid risk, work together and achieve long-term returns.
我们团队Our Team
刘雯渶Wenying Liu 美格咨询创始人Founder
刘雯渶女士在中国区域销售资本市场有十五年以上的工作经验，在2002年从最基本的销售职员做起到带领销售团队、区域总监，积累了广泛的人脉关系，特别是在华东区域。她见证了中国从2000年到2016年的发展历程，涉及的专业领域有传媒、家族工厂、资本运作。为一个新创企业进行全盘策划、企业形象、销售和品牌定位她有着丰富的经验。近五年来深度参与生物制药行业的交易和科研项目，积累了广泛的人脉资源。Ms. Wenying Liu has more than fifteen years of experience in capital-market sales across China. Starting in 2002 as a front-line sales associate, she rose to lead sales teams and serve as a regional director, building an extensive network of relationships, particularly in East China. She witnessed China's development from 2000 to 2016 first-hand, with professional experience spanning media, family-owned manufacturing businesses and capital operations. She has extensive experience in the overall planning of a new venture — its corporate image, sales and brand positioning. In the past five years, she has been deeply involved in biopharmaceutical transactions and research projects, building an extensive network in the field.
张锦华Leo Zhang 董事总经理、合伙人Managing Director, Partner
张锦华先生是一位拥有15年投行、股权投资和战略咨询经验的资深专业人士，专注于推动国际企业增长和制定创新战略。他在人工智能、区块链、新能源、TMT以及高端制造等领域具备深厚的专业知识，善于结合市场洞察力、财务技能和与相关方的协作能力。他拥有众多国际合作经验，包括IPO、SPAC和跨境投资，并为跨国企业提供投资、并购、重组及IPO方面的战略咨询服务，通过战略投资创造价值并优化投资组合表现。张先生毕业于麻省理工学院（MIT）并获得工商管理硕士（MBA）学位。Mr. Leo Zhang is a senior professional with 15 years of experience in investment banking, private equity and strategic consulting, focused on driving the growth of international companies and formulating innovative strategies. He has deep expertise in artificial intelligence, blockchain, new energy, TMT and high-end manufacturing, and excels at combining market insight and financial skill with effective stakeholder collaboration. He has extensive international transaction experience, including IPOs, SPACs and cross-border investments, and provides multinational companies with strategic advisory services on investment, mergers and acquisitions, restructuring and IPOs, creating value through strategic investment and optimising portfolio performance. Mr. Zhang graduated from the Massachusetts Institute of Technology (MIT) with a Master of Business Administration (MBA) degree.
段志华Duan Zhihua 美格咨询副总经理Deputy General Manager
段志华拥有美国法律学位，在中国金融业从业八年多，与中国上市公司，VC/PE公司，证券公司，投资银行，资产管理公司，高净值客户等建立了合作伙伴关系。他非常了解中美投资界的商业文化，对中美金融市场也非常了解。段先生可以为海外科技企业提供中国投资者和资本市场建立联系的全方位服务。凭借深厚的法律背景和对中国金融法规的了解，段先生为海外科技企业提供信息、法律和法规等咨询服务。Mr. Duan Zhihua holds a U.S. law degree and has worked in China's financial industry for more than eight years, building partnerships with Chinese listed companies, VC/PE firms, securities companies, investment banks, asset management companies and high-net-worth clients. He understands the business culture of the Chinese and U.S. investment communities very well, and knows both financial markets thoroughly. Mr. Duan provides overseas technology companies with a full range of services for establishing connections with Chinese investors and capital markets. Drawing on his solid legal background and his knowledge of Chinese financial regulations, he also provides overseas technology companies with advisory services on information, legal and regulatory matters.
王力伟Lydia Wang 香港会计师Hong Kong Accountant
王力伟女士会计学硕士，毕业于香港岭南大学。Beta Gamma Sigma（国际荣誉商学组织）岭南大学分支会员。她从事财务及审计工作近十年，行内经验丰富，香港注册会计师公会会员，她主要为MEGS处理一切财务事宜。Ms. Lydia Wang holds a master's degree in accounting and graduated from Lingnan University in Hong Kong. She is a member of the Lingnan University chapter of Beta Gamma Sigma, the international business honour society. She has worked in finance and auditing for nearly ten years, with extensive industry experience, and is a member of the Hong Kong Institute of Certified Public Accountants. She handles all financial matters for MEGS.
业务领域Services
专注于涉及AI、医药、科技等领域的跨境交易服务，并为客户推荐美国信托等投资资产的机会。We focus on cross-border transaction services in AI, pharmaceuticals, technology and related fields, and introduce our clients to opportunities in investment assets such as U.S. trusts.
投资服务Investment services
对接跨境投资机会，协助企业完成投资交易Connecting cross-border investment opportunities and helping companies complete investment transactions.
融资解决方案Financing solutions
为企业设计并对接跨境融资方案Designing and arranging cross-border financing solutions for companies.
专利管理与授权Patent management & licensing
协助专利资产的管理、授权与跨境合作Assisting with patent asset management, licensing and cross-border collaboration.
并购咨询M&A advisory
为跨境并购交易提供咨询与对接服务Advisory and introduction services for cross-border M&A transactions.
跨境战略合作Cross-border strategic partnerships
为企业寻找并促成国际战略合作伙伴Finding and bringing together international strategic partners for companies.
美国信托服务对接U.S. trust service introductions
推荐并对接美国信托等投资资产的第三方服务。We connect clients with third-party services for U.S. trusts and other investment assets. All such services are provided directly by the licensed providers.
服务行业Sectors
生命科学Life Sciences
人工智能Artificial Intelligence
电子通讯Electronics & Communications
能源行业Energy
发展历程History
2012.11.01
美格进军外贸Megs expands into foreign trade
2016.08.25
美格踏入投资、咨询Megs moves into investment and advisory
精选项目Selected Projects
2016–2020
2016–2020 · 量子科技 · 跨境合作与产业化落地2016–2020 · Quantum technology · Cross-border partnership and industrialization
2016–2020 · 新能源 · 海外科技企业区域落地与运营2016–2020 · New energy · Regional setup and operations for an overseas technology company
2016–2020 · 生物医药 · 技术转型与国际化2016–2020 · Biopharma · Technology transformation and internationalization
2020–2025
2020–2025 · 能源电力 · 战略合作与生产布局2020–2025 · Energy & power · Strategic partnership and production footprint
2020–2025 · 保健品 · 跨境并购与股权投资2020–2025 · Health supplements · Cross-border M&A and equity investment
2020–2025 · 制药 · 股权出售与买家对接2020–2025 · Pharmaceuticals · Equity sale and buyer introduction
2020–2025 · 创新药 · 战略合作伙伴对接2020–2025 · Innovative medicines · Strategic partner introduction
2020–2025 · 生物医药 · FDA三期产品License-out合作2020–2025 · Biopharma · License-out partnership for an FDA Phase III product
2020–2025 · 医疗器械 · 海外技术引进与推广2020–2025 · Medical devices · Overseas technology introduction and promotion
2020–2025 · 保健品 · 美国市场落地与IPO筹备2020–2025 · Health supplements · U.S. market entry and IPO preparation
交易机会Transaction Opportunities
中国医药早期资产Early-Stage Pharmaceutical Assets in China
按您的需要提供对应的项目投资机会。Investment opportunities matched to your needs, provided on request.
海外需求项目机会Overseas Demand Opportunities
按您的需要提供对应的项目投资机会。Investment opportunities matched to your needs, provided on request.
本栏目汇集中国早期医药与生物科技资产，包括创新药项目与生物科技平台，寻求海外合作伙伴、授权合作与投资对接。具体项目信息将在联系后提供。This section brings together early-stage pharmaceutical and biotech assets in China, including innovative drug projects and biotech platforms, seeking overseas partners, licensing collaborations and investment. Details of individual projects are provided once you get in touch.
本栏目汇集海外科技企业与投资人的需求方向，包括对中国医疗健康与科技资产的收购、项目合作与战略投资意向。具体需求情况将在联系后分享。This section brings together demand from overseas technology companies and investors, including acquisitions, project partnerships and strategic investment interest in Chinese healthcare and technology assets. Details of individual requirements are shared once you get in touch.
投资机会Investment Opportunities
美国医疗房地产U.S. Healthcare Real Estate
按您的需要提供对应的项目投资机会。Investment opportunities matched to your needs, provided on request.
美国数字资产与AI基础设施U.S. Digital Assets & AI Infrastructure
按您的需要提供对应的项目投资机会。Investment opportunities matched to your needs, provided on request.
专注于美国医疗类地产的投资机会：组合持有逾百处医疗物业，以医疗办公楼、诊所等医疗设施为主，租户以医疗机构为主、租约期长。Investment opportunities in U.S. healthcare real estate: a portfolio of more than one hundred healthcare properties, mainly medical office buildings, clinics and similar facilities, with healthcare tenants on long-term leases.
本项目以代币化形式参与数据中心、电力等AI基础设施与能源资产，将实体资产与数字权益相连接。Through tokenization, this project takes part in AI infrastructure and energy assets — data centers, power and similar assets — linking physical assets with digital interests.
它为投资者提供了一条参与AI算力基础设施成长的通道，得以分享人工智能算力建设的发展机遇。It gives investors a way to take part in the growth of AI computing infrastructure and to share in the expansion of AI computing capacity.
留下您的姓名、公司、职位、邮箱和需求，我们会即时回复您邮件。Leave your name, company, title, email address and your needs, and we will reply by email right away.
已解锁 — 全部机会的详细介绍已显示在各机会卡片中。Unlocked — full details for every opportunity now appear in the cards.
项目咨询：projects@megsinv.comProject enquiries: projects@megsinv.com
我们收到您的邮件，将发送项目材料并提供对接服务。When we receive your email, we will send the project materials and provide introduction services.
联系方式：General enquiries: info@megsinv.com
合作联系：Partnerships: partner@megsinv.com
美格投资有限公司MEGS Investments Limited
注册地址：香港九龍觀塘鴻圖道77號
潤承大廈4樓8室Registered address: Room 08, 4/F, Milkyway Building,
No. 77 Hung To Road, Kwun Tong, Kowloon, Hong Kong